X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anti-pd-l1 antibody (491) 491
index medicus (391) 391
immunotherapy (363) 363
oncology (330) 330
humans (320) 320
cancer (215) 215
safety (173) 173
nivolumab (139) 139
pd-l1 (139) 139
tumors (120) 120
female (114) 114
immunology (112) 112
animals (103) 103
chemotherapy (98) 98
anti-pd-l1 (97) 97
melanoma (97) 97
pembrolizumab (93) 93
pd-1 (92) 92
lymphocytes (91) 91
care and treatment (90) 90
apoptosis (89) 89
male (87) 87
t-cells (87) 87
ipilimumab (86) 86
middle aged (85) 85
clinical activity (84) 84
antibodies, monoclonal - therapeutic use (83) 83
b7-h1 antigen - metabolism (82) 82
open-label (82) 82
prognosis (82) 82
immunotherapy - methods (80) 80
pd-l1 expression (80) 80
aged (79) 79
blockade (79) 79
pd-1 blockade (79) 79
expression (75) 75
metastasis (74) 74
b7-h1 antigen - antagonists & inhibitors (71) 71
immunohistochemistry (71) 71
lung cancer (70) 70
pd-l1 protein (70) 70
tumor-infiltrating lymphocytes (68) 68
antineoplastic agents - therapeutic use (67) 67
b7-h1 antigen - immunology (67) 67
immune checkpoint (67) 67
ligands (66) 66
programmed cell death 1 receptor - antagonists & inhibitors (64) 64
neoplasms - immunology (62) 62
t cells (62) 62
biomarkers (59) 59
cell lung-cancer (59) 59
adult (58) 58
article (58) 58
cell biology (58) 58
cell death (58) 58
cancer therapies (56) 56
survival (56) 56
patients (54) 54
lymphocytes t (52) 52
pd-1 protein (52) 52
programmed cell death 1 receptor - immunology (52) 52
metastatic melanoma (50) 50
ctla-4 blockade (49) 49
antigens (48) 48
clinical trials (48) 48
mice (48) 48
mutation (48) 48
review (48) 48
carcinoma (47) 47
therapy (47) 47
treatment outcome (47) 47
antibodies (46) 46
health aspects (46) 46
pathology (46) 46
b7-h1 antigen - genetics (45) 45
research (45) 45
tumor microenvironment (45) 45
medicine, research & experimental (44) 44
gene expression (43) 43
medical prognosis (43) 43
programmed cell death 1 receptor - metabolism (43) 43
advanced melanoma (42) 42
analysis (42) 42
anti-pd-1 (42) 42
immune system (42) 42
lung neoplasms - pathology (42) 42
docetaxel (41) 41
lung neoplasms - drug therapy (40) 40
dendritic cells (39) 39
drug therapy (39) 39
b7-h1 (38) 38
lung cancer, non-small cell (38) 38
mpdl3280a (37) 37
pharmacology & pharmacy (37) 37
aged, 80 and over (36) 36
breast cancer (36) 36
checkpoint blockade (36) 36
immune response (36) 36
cell line, tumor (35) 35
cytotoxicity (35) 35
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 54, pp. 139 - 148
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 587 - 598
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2017, Volume 141, Issue 3, pp. 583 - 593
Journal Article
Cancer Immunology Research, ISSN 2326-6066, 10/2015, Volume 3, Issue 10, pp. 1148 - 1157
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 06/2017, Volume 215, Issue 11, pp. 1725 - 1733
Journal Article
Cancer Cell, ISSN 1535-6108, 09/2015, Volume 28, Issue 3, pp. 285 - 295
Journal Article
Oncology (Switzerland), ISSN 0030-2414, 02/2017, Volume 92, Issue 1, pp. 50 - 62
Clinical trials of antibodies targeting the immune checkpoint inhibitors programmed cell death 1 (PD-1), programmed cell death ligand 1 (PD-L